Accounts Receivable, after Allowance for Credit Loss, Current in USD of SINOVAC BIOTECH LTD from Q4 2010 to Q4 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
SINOVAC BIOTECH LTD quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2010 to Q4 2023.
- SINOVAC BIOTECH LTD Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2023 was $440,019,000, a 18.1% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)